IDXX

Conviction 19HealthcareScan · Mon, Jul 20, 2026

IDXX$563.73-0.65%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 692.95K

Apr 20May 6May 26Jun 11Jul 1Jul 20

IDEXX LABORATORIES INC /DEIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.idexx.com ↗

Price563.73

Change-0.65%

Gap+0.22%

Rel volume0.84×

Avg volume718.38K

Avg $ vol397.5M

SMA 20554.13

SMA 50554.83

SMA 200623.77

Price vs 50+1.60%

Price vs 200-9.63%

MA stackmixed

50/200 cross—

Supertrenddown · 581.11

RSI (14)52

MACD hist1.69

MACD cross—

Stoch %K / %D72 / 80

ADX (14)10

+DI / −DI23 / 20

RSI divergence—

MACD divergence—

ATR %+3.24%

ADR %3.23%

52w high766.68

52w low514.61

From 52w high-26.47%

Above 52w low+9.55%

New 52w highNo

SqueezeOff

Bollinger width9.11%

%B0.69

Donchian pos71.92%

Donchian high581.37

Donchian low518.55

AVWAP (52w high)606.65

vs AVWAP high-7.07%

AVWAP (52w low)621.24

vs AVWAP low-9.26%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d0.84×

Avg vol (14d)692.95K

Avg vol (20d)718.38K

Avg $ vol (20d)397.5M

Market cap44.47B

RS 3m (vs SPY)-6.37%

RS 6m (vs SPY)-27.80%

RS line new highNo

Trend template1/8

Technical rank38.5

1 week-0.09%

1 month+3.23%

3 months-4.33%

6 months-20.84%

1 year+8.68%

YTD-15.86%

P/E41.97

P/B28.58

P/S10.33

P/FCF42.07

EPS13.08

Div yield—

ROE68.08%

ROA31.29%

Debt/Eq0.29

Current1.12

EV/EBITDA29.71

Gross margin61.80%

Net margin24.62%

Rev growth10.42%

EPS growth19.33%

Price target714.40

Target upside26.73%

Analyst ratingBuy

Institutional107.26%

Ent. value44.72B

Revenue1.14B

Net income278.45M

Gross profit722.74M

Free cash flow1.06B

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out78.88M

Employees11K

ListedFri, Jun 21, 1991

Free float78.58M

Float %99.6%

Short interest1.94M

Days to cover2.5d

Short volume52.9%

Squeeze score26 / 100

Next earningsTue, Aug 4, 2026 · pre-mkt (15d)

EPS forecast$3.95 · 6 est

Last EPS vs est$3.47 vs $3.42

Last surprise+1.5% beat

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank38.5 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance580.11

Support527.35

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 32 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Breaking out now
Jun 9
1 scan
→
Setting up
Jun 15 – Jun 16
2 scans

Congress activity

Disclosed STOCK Act trades in IDXX · 10 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
April McClain Delaney house · D · MD · traded 2026-01-13	Sell	$1K–$15K	2026-01-13	2026-02-02	PDF
Byron Donalds house · R · FL · traded 2025-09-04	Buy	$1K–$15K	2025-09-04	2025-10-07	PDF
April McClain Delaney house · D · MD · traded 2025-08-07	Sell	$1K–$15K	2025-08-07	2025-09-02	PDF
April McClain Delaney house · D · MD · traded 2025-07-09	Sell	$1K–$15K	2025-07-09	2025-08-05	PDF
Jefferson Shreve house · R · IN · traded 2025-05-12	Sell	$100K–$250K	2025-05-12	2025-06-22	PDF
Rob Bresnahan house · PA · traded 2025-05-15	Buy	$1K–$15K	2025-05-15	2025-06-09	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Buy	$50K–$100K	2025-04-07	2025-05-08	PDF
April McClain Delaney house · D · MD · traded 2025-04-09	Buy	$1K–$15K	2025-04-09	2025-05-02	PDF
April McClain Delaney house · D · MD · traded 2025-04-04	Buy	$1K–$15K	2025-04-04	2025-05-02	PDF
April McClain Delaney house · D · MD · traded 2025-04-07	Buy	$1K–$15K	2025-04-07	2025-05-02	PDF

Insider activity

SEC Form 4 transactions in IDXX · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
FENNELL GEORGE Executive Vice President · Restricted Stock Unit · 2026-06-01	Exercise	639	—	2026-06-01	2026-06-02
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01	Tax	284	$161K	2026-06-01	2026-06-02
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01	Exercise	639	$0	2026-06-01	2026-06-02
Kingsley Lawrence D Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
ESSIG STUART Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
SAMAD SAM Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
ESSIG STUART Director · Restricted Stock Unit · 2026-05-12	Grant	234	$0	2026-05-12	2026-05-14
HOOLEY JOSEPH L Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
Britt Irene Chang Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
JUNIUS DANIEL M Director · Restricted Stock Unit · 2026-05-12	Grant	234	$0	2026-05-12	2026-05-14

SEC filings

EDGAR filings in IDXX

EDGAR →

No recent SEC filings on file for IDXX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.